1997
DOI: 10.1006/niox.1996.0106
|View full text |Cite
|
Sign up to set email alerts
|

Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2B

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
275
3
5

Year Published

2002
2002
2015
2015

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 352 publications
(288 citation statements)
references
References 20 publications
5
275
3
5
Order By: Relevance
“…We also reported recently that SDMA is a prospective marker of total mortality after ischemic stroke (19). Several explanations for this observation including increased formation of reactive oxygen species, competition for L-arginine transport into endothelial cells, or valid reflection of renal function by SDMA have been proposed (18,20,21).…”
Section: Introductionmentioning
confidence: 79%
“…We also reported recently that SDMA is a prospective marker of total mortality after ischemic stroke (19). Several explanations for this observation including increased formation of reactive oxygen species, competition for L-arginine transport into endothelial cells, or valid reflection of renal function by SDMA have been proposed (18,20,21).…”
Section: Introductionmentioning
confidence: 79%
“…6C), suggesting a possible role of CAT-2B in the regulation of extracellular L-arginine and CD3 expression. Although L-NMMA can also inhibit iNOS activity, we have used L-SDMA and Llysine, which do not inhibit iNOS at the concentration used (1 mM) (24). In addition, iNOS inhibitors L-NIL, L-NNA, and L-NAME, which are not transported by CAT-2B failed to recover CD3 expression after T cell stimulation.…”
Section: Discussionmentioning
confidence: 99%
“…11 Symmetric dimethylarginine (SDMA) does not inhibit endothelial NO synthase, but it interferes with Larginine uptake via the y þ carrier into the endothelial cells. 12 Both ADMA and SDMA are risk markers for vascular disease, 13 --18 while SDMA is also reported to predict renal damage. 19 L-arginine supplementation improves the reduced vasodilatory response in offspring of hypertensive patients and in normotensive patients with familial essential hypertensive histories, suggesting that a genetic predisposition to essential hypertension involves a defect in NO generation.…”
Section: Introductionmentioning
confidence: 99%